SARS-CoV-2 DNA vaccine (Immunomic Therapeutics/EpiVax)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSARS-CoV-2 DNA vaccine (Immunomic Therapeutics/EpiVax)
Drug Alias Namenucleic acid based vaccine (Immunomic Therapeutics/EpiVax)nucleic acid based vaccine(Immunomic Therapeutics/EpiVax)plasmid DNA vaccine(Immunomic Therapeutics/EpiVax)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunomic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpiVax IncImmunomic Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A